MAR 29, 2021 8:00 AM PDT

Design and performance characteristics of Alinity m Resp-4-Plex assay

Speakers
  • Director, Division of Infectious Disease Diagnostics - Department of Pathology and Laboratory Medicine Northwell Health Laboratories
    Biography

      Dr. Berry received his Ph.D. Microbiology and Immunology from Penn State University College of Medicine and completed a fellowship in Medical and Public Health Microbiology at the University of Texas Medical Branch. He is currently an Assistant Professor of Pathology and Laboratory Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Director of the Division of Infectious Disease Diagnostics at Northwell Health Laboratories. Dr. Berry specializes in the application of infectious disease testing for the clinical diagnosis of disease and patient management. He is also a Diplomate of the American Board of Medical Microbiology.

    • Sr. Director of Assay Development, Molecular Diagnostics at Abbott
      Biography

        Dr. Huang received his Ph.D. in Biological Sciences from Northwestern University. He is the Senior Director of Assay Development, at Molecular Diagnostics. Dr. Huang has been developing molecular diagnostic products for the last 19 years at Abbott. He is currently leading assay development on the fully automated Alinity m System.


      Abstract

      Date:  March 29, 2021

      Time: 8:00am PDT,  11:00am EDT

       

      Influenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different viruses. COVID-19 is caused by infection with a new coronavirus (called SARS-CoV-2), and Flu is caused by infection with influenza viruses.1 Due to symptom similarities between Flu and COVID-19, testing is needed to help confirm a diagnosis.1  Being able to simultaneously identify patient’s infection status allows physicians the ability to provide optimal treatment decisions and control further disease transmission.  Alinity m Resp-4-Plex assay provides simultaneous qualitative detection and differentiation of Flu A, Flu B, Respiratory Syncytial Virus (RSV) and SARS-CoV-2 on the fully automated Alinity m system.  This webinar will discuss the design, development and clinical performance of the Alinity m Resp-4-Plex assay. 

       

      Learning Objectives:

      • Discuss Respiratory Disease State and Current Trends Overview
      • Discuss the Alinity m Resp-4-Plex Assay Design
      • Discuss Alinity m Resp-4-Plex Assay Clinical Performance 

       

       

      Webinars will be available for unlimited on-demand viewing after live event.

       

       


      Show Resources
      You May Also Like
      FEB 24, 2021 10:00 AM PST
      C.E. CREDITS
      FEB 24, 2021 10:00 AM PST
      DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
      DEC 03, 2020 4:30 PM PST
      C.E. CREDITS
      DEC 03, 2020 4:30 PM PST
      This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
      JAN 21, 2021 8:00 AM PST
      JAN 21, 2021 8:00 AM PST
      Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
      NOV 19, 2020 8:00 AM GMT
      C.E. CREDITS
      NOV 19, 2020 8:00 AM GMT
      Date: November 19, 2020 Time: 12:00am (PDT), 9:00am (CET), 4:00pm (SGT) We present split-FISH, a multiplexed fluorescence in situ hybridization method that leverages a split-probe design to...
      APR 21, 2021 10:00 AM PDT
      C.E. CREDITS
      APR 21, 2021 10:00 AM PDT
      Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
      NOV 18, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 18, 2020 8:00 AM PST
      DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
      Loading Comments...
      Show Resources
      Attendees
      • See more